These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 25569674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis.
    Zimmermann P, Finn A, Curtis N.
    J Infect Dis; 2018 Jul 24; 218(5):679-687. PubMed ID: 29635431
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology of Buruli ulcer in Amansie West district, Ghana.
    Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH.
    Trans R Soc Trop Med Hyg; 1993 Jul 24; 87(6):644-5. PubMed ID: 8296362
    [Abstract] [Full Text] [Related]

  • 5. BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
    Converse PJ, Almeida DV, Nuermberger EL, Grosset JH.
    PLoS Negl Trop Dis; 2011 Mar 15; 5(3):e985. PubMed ID: 21423646
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
    Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH, Amofah GK, Ofori-Adjei D, Dobos K, Guarner J, Martin S, Pathak S, Klutse E, Etuaful S, van der Graaf WT, van der Werf TS, King CH, Tappero JW, Ashford DA.
    Clin Infect Dis; 2005 May 15; 40(10):1445-53. PubMed ID: 15844067
    [Abstract] [Full Text] [Related]

  • 8. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.
    Nackers F, Dramaix M, Johnson RC, Zinsou C, Robert A, DE Biurrun Bakedano E, Glynn JR, Portaels F, Tonglet R.
    Am J Trop Med Hyg; 2006 Oct 15; 75(4):768-74. PubMed ID: 17038709
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C, Lévy-Bruhl D, Bingono E, Siopathis RM, Guérin N.
    Int J Epidemiol; 1995 Oct 15; 24(5):1042-9. PubMed ID: 8557438
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis.
    Muhi S, Stinear TP.
    Vaccine; 2021 Dec 08; 39(50):7238-7252. PubMed ID: 34119347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
    Lancet; 1996 Jul 06; 348(9019):17-24. PubMed ID: 8691924
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP, Ambadekar NN, Thakur A.
    Public Health; 2005 Mar 06; 119(3):209-16. PubMed ID: 15661132
    [Abstract] [Full Text] [Related]

  • 20. Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo.
    Phanzu DM, Suykerbuyk P, Imposo DB, Lukanu PN, Minuku JB, Lehman LF, Saunderson P, de Jong BC, Lutumba PT, Portaels F, Boelaert M.
    PLoS Negl Trop Dis; 2011 Dec 06; 5(12):e1402. PubMed ID: 22216362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.